Malaysian CRO Company Survey

1. Type or Nature of your Business Operation?

a) Agro biotech

b) Biopharmaceuticals

c) Nutraceuticals

d) Diagnostics

e) Industrial Enzymes

f) Pharma-Generics

g) CRO

Other

2. Would you check all the boxes showing the areas your firm/R&D’s work is related to? (As many as you find them relevant)

3. Do you have any compounds/Molecules in Preclinical stage? If yes please specify the category

4. How do you expect your company’s drug pipeline to change over the next two to three? Years by phase of development?

5. Is Government subsidy availed?

a. Yes

b. No

6. How many external collaborations has your firm/R&D division done within 5 years/10years? (Check only one box in each column)* The external collaborations include any type of outsourcing, partnership, or contracts with outside experts/any type of institutes (universities or companies)

7. What is the impact of the external collaborations on the performance of your firm? How would you rate them?

a) Well below expectations

b) Somewhat below expectations

c) Neutral

d) Somewhat above expectations

e) Well above expectations

8. Have your outsourcing strategies changed over the past one to two years in terms Of percentage and value in dollars outsourced?

a) Increased the Percentage of Outsourcing

b) Decreased the Percentage of Outsourcing

c) Building in-house capabilities

d) No Change

9. How do you envision strategic partnerships will change the nature of your company’s Outsourcing to CROs?

a) Strategic Relationship with one CRO

f) Longer contracts [three to five years)

g) More risk-sharing deals

h) More asset transfer

i) No change

10. When you are Outsourcing the Pre-Clinical work, What are the certification(s) you will be Looking for a CRO?